T-cell prolymphocytic leukemia other diagnostic studies: Difference between revisions
No edit summary |
No edit summary |
||
| Line 2: | Line 2: | ||
{{T-cell prolymphocytic leukemia}} | {{T-cell prolymphocytic leukemia}} | ||
{{CMG}}; {{AE}}{{Qurrat}}, {{MV}} | {{CMG}}; {{AE}}{{Qurrat}}, {{MV}} | ||
==Other Diagnostic Studies== | ==Other Diagnostic Studies== | ||
Revision as of 20:15, 28 March 2019
|
T-cell prolymphocytic leukemia Microchapters |
|
Differentiating T-cell prolymphocytic leukemia historical perspective from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
T-cell prolymphocytic leukemia other diagnostic studies On the Web |
|
American Roentgen Ray Society Images of T-cell prolymphocytic leukemia other diagnostic studies |
|
FDA on T-cell prolymphocytic leukemia other diagnostic studies |
|
CDC on T-cell prolymphocytic leukemia other diagnostic studies |
|
T-cell prolymphocytic leukemia other diagnostic studies in the news |
|
Blogs on T-cell prolymphocytic leukemia other diagnostic studies |
|
Risk calculators and risk factors for T-cell prolymphocytic leukemia other diagnostic studies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Qurrat-ul-ain Abid, M.D.[2], Maria Fernanda Villarreal, M.D. [3]
Other Diagnostic Studies
Flow cytometry and immunohistopathology must be done to diagnose T-cell prolymphocytic leukemia.